AR045950A1 - Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos. - Google Patents

Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos.

Info

Publication number
AR045950A1
AR045950A1 ARP040103493A ARP040103493A AR045950A1 AR 045950 A1 AR045950 A1 AR 045950A1 AR P040103493 A ARP040103493 A AR P040103493A AR P040103493 A ARP040103493 A AR P040103493A AR 045950 A1 AR045950 A1 AR 045950A1
Authority
AR
Argentina
Prior art keywords
alkyl
alk
atom
absent
groups
Prior art date
Application number
ARP040103493A
Other languages
English (en)
Spanish (es)
Original Assignee
Speedel Experimenta Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Experimenta Ag filed Critical Speedel Experimenta Ag
Publication of AR045950A1 publication Critical patent/AR045950A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP040103493A 2003-10-09 2004-09-27 Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos. AR045950A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH17252003 2003-10-09

Publications (1)

Publication Number Publication Date
AR045950A1 true AR045950A1 (es) 2005-11-16

Family

ID=34438156

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103493A AR045950A1 (es) 2003-10-09 2004-09-27 Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos.

Country Status (3)

Country Link
AR (1) AR045950A1 (fr)
TW (1) TW200528449A (fr)
WO (1) WO2005037803A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1707206A1 (fr) * 2005-03-31 2006-10-04 Speedel Experimenta AG Dérivés de piperazine pour l'inhibition de la beta-secretase, de la cathepsine d, de la plasmepsin ii et de la protease de vih et pour le traitement de la malaria, de la maladie d'alzheimer et du sida
GB0511063D0 (en) * 2005-05-31 2005-07-06 Novartis Ag Organic compounds
WO2007034445A2 (fr) * 2005-09-26 2007-03-29 Actelion Pharmaceuticals Ltd Nouveaux derives de la piperazine
WO2007049224A1 (fr) * 2005-10-25 2007-05-03 Actelion Pharmaceuticals Ltd Nouveaux derives d'hexahydro- ou d'octahydro-cyclopenta[c]pyrrole
WO2008074450A2 (fr) * 2006-12-20 2008-06-26 Nicox S.A. Dérivés nitrés d'inhibiteurs non peptidiques de la rénine
JP5092111B2 (ja) * 2007-02-05 2012-12-05 トーアエイヨー株式会社 ブトキシアニリン誘導体
WO2009022730A1 (fr) * 2007-08-10 2009-02-19 Nippon Chemiphar Co., Ltd. Antagoniste de récepteur p2x4
TW200932241A (en) 2007-12-05 2009-08-01 Speedel Experimenta Ag Organic compounds
UY33535A (es) * 2010-08-13 2011-12-01 Biolab Sanus Farmaceutuca Limitada Derivados de 6,7-dihidro-3h-oxazolo[3,4]pirazin-5,8-diona
CA2864606C (fr) 2012-02-15 2021-06-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Procedes de traitement et de prevention de maladies et de troubles du systeme nerveux central
AR099523A1 (es) * 2014-02-24 2016-07-27 Biolab Sanus Farmacêutica Ltda Compuestos derivados de 6,7-dihidro-3h-oxazolo[3,4-a]pirazina-5,8-diona

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199800409T1 (xx) * 1995-09-07 1998-05-21 F.Hoffmann-La Roche Ag Kalp ve b�brek yetersizli�inin tedavii�in yeni 4-(oksialkoksifenil)-3-oksi-piperidinler
US6197959B1 (en) * 1999-04-27 2001-03-06 Hoffmann-La Roche Inc. Piperidine derivatives
US6376672B1 (en) * 1999-04-27 2002-04-23 Hoffmann-La Roche Inc. Naphthalenylmethoxypiperidines as renin inhibitors
GB0119797D0 (en) * 2001-08-14 2001-10-03 Glaxo Group Ltd Chemical compounds
US20040214832A1 (en) * 2003-04-10 2004-10-28 Cuiman Cai Piperazine derivative renin inhibitors

Also Published As

Publication number Publication date
TW200528449A (en) 2005-09-01
WO2005037803A1 (fr) 2005-04-28

Similar Documents

Publication Publication Date Title
AR065188A2 (es) Piperidinas sustituidas, preparacion farmaceutica y uso de dichas piperidinas para preparar medicamentos
CY1106679T1 (el) Αζαδικυκλικες ετεροκυκλικες ενωσεις ως τροποποιητες κανναβινοειδους υποδοχεα
NO20021399L (no) Kazolinderivater og deres anvendelse som farmasöyter
CY1106674T1 (el) Αζαδικυκλικοι ετεροκυκλοι σαν ρυθμιστες υποδοχεα κανναβινοειδους
CY1105899T1 (el) Πυριδινοϋλοπιπepιδινες ως 5-ht1f αγωνιστες
AR053405A1 (es) Derivados de urea sustituidas, composiciones farmaceuticas y metodos para el tratamiento de cardiopatias
DK1265606T3 (da) Celleadhæsionsinhibitorer
AR074435A1 (es) Derivados de 1,3-benzotiazol, medicamentos que los contienen y uso de los mismos en el tratamiento del cancer.
DK1313695T3 (da) Estere af 5-aminolevulinsyre som fotosensibiliserende midler i fotokemoterapi
NO20082389L (no) 2,3,4-trifenylimidazolinderivater som inhibitor av interaksjonen mellom P53- og MDM2-proteiner for anvendelse som antikreftmidler
AR025976A1 (es) Inhibidores de fab i.
UA25969A1 (uk) Похідні n-(4-піперидиніл) (дигідробензофуран або дигідро-2н-бензопіран) карбоксиамід або їх солі, або їх стереоізомери, які стимулюють гастрокишкову систему, спосіб їх одержання, проміжні сполуки для них, фармацевтична композиція на основі похідних n-(4-піперидиніл)(дигідробензофуран або дигідро-2н-бензопіран) карбоксиаміду, яка стимулює гастрокишкову систему
AR052330A1 (es) Derivados de adamantano que comprenden quinoleinas sustituidas
AR045950A1 (es) Compuestos derivados de piperazina, composiciones farmaceuticas que los contienen y su uso en la fabricacion de medicamentos.
NO20053762L (no) Kondensert furanforbindelse.
AR040257A1 (es) Profarmacos de aminoacidos excitadores
RU2008142600A (ru) Органическое соединение
NO20062272L (no) Fremgangsmater og sammensetninger for selektin inhibisjon
ATE374773T1 (de) Polycyclische verbindungen als potenten alpha2- adrenoceptor antagonisten
NO20062348L (no) Fremgangsmater og sammensetninger for selektin inhibisjon
BG104717A (en) Water soluble azoles as broad-spectrum antifungals
NO20062307L (no) Spirofuropyridinarylderivater
NO974690L (no) Nye triazoloner som inhibitorer av apolipoprotein B-syntesen
DE60144246D1 (de) Imidazolderivate, verfahren zu deren herstellung und deren verwendung
DK1968957T3 (da) Substituerede thiazoler og anvendelse deraf til fremstilling af lægemidler

Legal Events

Date Code Title Description
FB Suspension of granting procedure